China Grand Enterprises

Read More

Read More

Read More

Read More

CGE BUSINESS

LATEST NEWS

MORE

Grand Pharma brings heavyweight products to the World Health Expo

Grandpharma (China) Co., Ltd. (00512.HK) (hereinafter referred to as Grand Pharma) participated in the 5th World Health Expo (hereinafter referred to as the Health Expo) with heavy products on April 7th. At the Health Expo, a series of innovative medical
12

Apr

2023

Grand Pharma brings heavyweight products to the World Health Expo

Grandpharma (China) Co., Ltd. (00512.HK) (hereinafter referred to as Grand Pharma) participated in the 5th World Health Expo (hereinafter referred to as the Health Expo) with heavy products on April 7th. At the Health Expo, a series of innovative medical

09

Nov

2022

Grand Pharma Recognized as a National Technology Innovation Demonstration Enterprise

On November 3rd, the Ministry of Industry and Information Technology of China announced the list of National Technology Innovation Demonstration Enterprises for 2022. Grand Pharmaceuticals (China) Co., Ltd. (hereinafter referred to as “Grand Pharma”)

06

Sep

2022

Globally innovative products Atectura® and Enerzair® developed by Grand Pharma officially enter the domestic market

On September 3, 2022, Beijing Grand Johamu Pharmaceutical Co., Ltd, one member enterprise in the respiratory and anti-severe-infection plate owned by Grand Pharma Group Co., Ltd. (0512.HK) (briefly known as Grand Pharma), held a product launch meeting.

24

Aug

2022

Accelerating Global Innovation, Opening Ceremony of Grand Pharma Optics Valley R&D Center and Extensive Intervention Production and R&D Platform

On August 19, 2022, the opening ceremony of Grand Pharma Wuhan Optics Valley R&D Center (“the Center”) and Extensive Intervention Production and R&D Platform (“the Platform”) was held at Donghu High-tech District Precision Medicine Industry Base, official

22

Jun

2022

SIR-Spheres® Yttrium-90 Microspheres Injections Introduced by Grandpharma Officially Launched in Chinese Market

On June 19, 2022, Grandpharma (0512.HK) announced that a "nuclear weapon" innovative medical product to treat liver malignant tumors -- SIR-Spheres® yttrium-90 microsphere injections (trademark in Chinese charters: 易甘泰®, read as “Yigantai”) was officiall

15

Apr

2022

Yuanda Shuyang's New Production Base for Blood Products Officially Put into Operation

On April 8, 2022, a new production base (West High-tech Zone) for blood products of Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. ("Yuanda Shuyang"), a wholly-owned subsidiary of Yuanda Life Science Group Co., Ltd, was officially put into operation

23rd Floor, Tower B of Grand Place, NO.5 Huizhong Road, Chaoyang District, Beijing, China 100101

（86-10）84891818 info@cgeinc.com

Copyright © 2017-2021 China Grand Enterprises, Inc. Beijing ICP No.10014261-2 Beijing Public Network Security No.11010502033526

Site Map | Contact Us | Legal Statement
| Copyright Statement